Setronon solutie injectabila 2 mg/ml Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

setronon solutie injectabila 2 mg/ml

pliva hrvatska d.o.o. - ondansetronum - solutie injectabila - 2 mg/ml

Sumamed comprimate filmate 125 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

sumamed comprimate filmate 125 mg

pliva hrvatska d.o.o. - azithromycinum - comprimate filmate - 125 mg

Sumamed pulbere pentru suspensie orala 100 mg/5 ml Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

sumamed pulbere pentru suspensie orala 100 mg/5 ml

pliva hrvatska d.o.o. - azithromycinum - pulbere pentru suspensie orala - 100 mg/5 ml

SUMAMED FORTE 200 mg/5 ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sumamed forte 200 mg/5 ml

pliva ljublijana d.o.o. - azithromycinum - pulb. pt. susp. orala - 200mg/5ml - macrolide, lincosamide si streptogramine macrolide

SUMAMED FORTE 200 mg/5 ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sumamed forte 200 mg/5 ml

pliva ljubljana d.o.o. - slovenia - azithromycinum - pulb. pt. susp. orala - 200mg/5ml - macrolide, lincosamide si streptogramine macrolide

Desloratadine ratiopharm Uniunea Europeană - română - EMA (European Medicines Agency)

desloratadine ratiopharm

ratiopharm gmbh - desloratadina - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antihistaminice pentru uz sistemic, - desloratadine ratiopharm is indicated in adults for the relief of symptoms associated with:allergic rhinitischronic idiopathic urticaria as initially diagnosed by a physician.

Imatinib Actavis Uniunea Europeană - română - EMA (European Medicines Agency)

imatinib actavis

actavis group ptc ehf - imatinib - leukemia, myelogenous, chronic, bcr-abl positive; precursor cell lymphoblastic leukemia-lymphoma; myelodysplastic-myeloproliferative diseases; hypereosinophilic syndrome; dermatofibrosarcoma - protein kinase inhibitors, antineoplastic agents - imatinib actavis is indicated for the treatment of: , paediatric patients with newly diagnosed philadelphia chromosome (bcr-abl) positive (ph+) chronic myeloid leukaemia (cml) for whom bone marrow transplantation is not considered as the first line of treatment;, paediatric patients with ph+ cml in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis;, adult patients with ph+ cml in blast crisis;, adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy;, adult patients with relapsed or refractory ph+ all as monotherapy;, adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements;, adult patients with advanced hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) with fip1l1-pdgfr rearrangement;, the treatment of adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. , efectul de imatinib pe rezultatul de transplantul de măduvă osoasă nu a fost determinată. imatinib actavis is indicated for: , in adult and paediatric patients, the effectiveness of imatinib is based on overall haematological and cytogenetic response rates and progression-free survival in cml, on haematological and cytogenetic response rates in ph+ all, mds/mpd, on haematological response rates in hes/cel and on objective response rates in adult patients with unresectable and/or metastatic dfsp. experiența cu imatinib la pacienții cu mds/mpd asociate cu genei fcdp-re-aranjamente este foarte limitat. nu există studii controlate care să demonstreze un beneficiu clinic sau a crescut de supraviețuire pentru aceste boli.

ATAZANAVIR TEVA 150 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

atazanavir teva 150 mg

pliva hrvatska d.o.o. (pliva croatia ltd.) - croatia - atazanavirum - caps. - 150mg - antivirale cu actiune directa inhibitori de proteaza

ATAZANAVIR TEVA 200 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

atazanavir teva 200 mg

pliva hrvatska d.o.o. (pliva croatia ltd.) - croatia - atazanavirum - caps. - 200mg - antivirale cu actiune directa inhibitori de proteaza

ATAZANAVIR TEVA 300 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

atazanavir teva 300 mg

pliva hrvatska d.o.o. (pliva croatia ltd.) - croatia - atazanavirum - caps. - 300mg - antivirale cu actiune directa inhibitori de proteaza